-
pharmaceutical engineering, materials chemistry, EV biology, immunology, protein and genetic engineering, and data science. The current focuses of our group include biohybrid lipid nanoparticle platform
-
collaborative research spans pharmaceutical engineering, materials chemistry, EV biology, immunology, protein and genetic engineering, and data science. The current focuses of our group include biohybrid lipid
-
technology and trends; participates as a team member with lab staff, collaborative researchers, and students and to interpret data and discuss project progress; collaborates with other researchers in
-
Sciences | Molecular Genetics Administration The College of Arts and Sciences is seeking a Post Doctoral Scholar position in the laboratory of Dr. Shuai Huang at The Ohio State University. The Huang lab
-
, obesity-related cancer, metabolism, cardiovascular, microbiome research, or the tumor microenvironment. · Experience with syngeneic or genetically engineered mouse models, flow cytometry, histology
-
. Xiaowen Bai’s laboratory. Dr. Bai’s research investigates how genetic risk factors interact with environmental exposures, such as alcohol and anesthetics, to drive neurodevelopmental and neurodegenerative
-
, and metabolic disorders. Experimental approaches include genetically engineered mouse models, MI and sepsis (CLP/LPS) models, aging and metabolic disease models, and molecular, cellular, imaging, and